SCHEMBL10712366

SCHEMBL10712366

Cc1cc(O)n(-c2ccc(N)cc2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
MAPK1 P28482 1/20 0.53
TERT O14746 1/20 0.48
LMNA P02545 3/20 0.47
RAB9A P51151 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
POLB P06746 1/20 0.46
NPC1 O15118 2/20 0.45
TSHR P16473 2/20 0.45
MAPT P10636 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ALDH1A1 P00352 5/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
FCGR1A P12314 1/20 0.43
HPGD P15428 1/20 0.43
ENPP3 O14638 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28620570 0.85 MAPK1 (0.47) CYP1A2CYP2C19MAPK1LMNARAB9A
SCHEMBL11441588 0.85 CYP1A2 (0.47) CYP1A2CYP2C19MAPK1LMNARAB9A
SCHEMBL200831 0.82 MAPK1 (0.63) CYP1A2CYP2C19MAPK1LMNARAB9A
SCHEMBL10906315 0.82 ALDH1A1 (0.54) CYP1A2CYP2C19MAPK1RAB9ASMN1; SMN2
SCHEMBL23400622 0.82 LMNA (0.54) CYP1A2CYP2C19MAPK1LMNARAB9A
SCHEMBL11436903 0.81 MAPK1 (0.44) CYP1A2CYP2C19MAPK1LMNARAB9A
SCHEMBL30490040 0.81 MAPT (0.47) CYP1A2CYP2C19MAPK1LMNARAB9A
SCHEMBL10707004 0.81 POLB (0.60) CYP1A2CYP2C19MAPK1LMNARAB9A
SCHEMBL8864119 0.81 CYP1A2 (0.72) CYP1A2CYP2C19MAPK1TERTLMNA
SCHEMBL1353576 0.81 TERT (0.66) CYP1A2CYP2C19MAPK1TERTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1983987-B1 DIHYDRODIAZEPINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMA (US) 2010-09-01 EP disclosed
US-7754273-B2 Method of printing a time-temperature indicator based on azo coupling reactions onto a susbtrate CIBA SPECIALTY CHEMICALS CORP. (US) 2010-07-13 US disclosed
US-7754273-B2 Method of printing a time-temperature indicator based on azo coupling reactions onto a susbtrate CIBA SPECIALTY CHEMICALS CORP. (US) 2010-07-13 US disclosed
US-20070218206-A1 Method of Printing a Time-Temperature Indicator Based on Azo Coupling Reactions onto a Susbtrate CIBA SPECIALTY CHEMICALS CORP. 2007-09-20 US disclosed
US-20070218206-A1 Method of Printing a Time-Temperature Indicator Based on Azo Coupling Reactions onto a Susbtrate CIBA SPECIALTY CHEMICALS CORP. 2007-09-20 US disclosed
WO-2007095188-A2 DIHYDRODIAZEPINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-08-23 WO disclosed
EP-0139090-B1 PROCESS FOR THE PRE-TREATMENT OF POLYIMIDES SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 EP disclosed
US-4517254-A ALKALI METAL HYDROXIDE, AMINOALKYLPOLYACID COMPOUNT SCHERING AKTIENGESELLSCHAFT (DE) 1985-05-14 US disclosed
EP-0139090-A1 Process for the pre-treatment of polyimides SCHERING AKTIENGESELLSCHAFT (DE) 1985-05-02 EP disclosed
US-4248632-A ACTIVATION OF A POLYMER SURFACE WITH A PALLADIUM COMPLEX SALT SCHERING AKTIENGESELLSCHAFT (DE) 1981-02-03 US disclosed